Chronic Lymphocytic Leukemia Clinical Trials

• High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002788 - Active, not recruiting
  stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
  
• Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004218 - Active, not recruiting
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003829 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
  
• Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00072007 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Fludarabine Followed by Campath-1H in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004857 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002838 - Active, not recruiting
  stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia
  
• Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003248 - Active, not recruiting
  stage II chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia; stage IV chronic lymphocytic leukemia; ...
  
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003764 - Active, not recruiting
  stage 0 chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Fludarabine and Rituximab Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00098670 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00096018 - Recruiting
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00049075 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00006226 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00017108 - Active, not recruiting
  stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003910 - Recruiting
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00006097 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004040 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage I multiple myeloma; stage II multiple myeloma; stage IV chronic lymphocytic leukemia; ...
  
• Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003659 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia
  
• Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00024440 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• LMB-2 Immunotoxin in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00080821 - Recruiting
  refractory chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00005829 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00058240 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; Waldenstrom's Macroglobulinemia; recurrent small lymphocytic lymphoma
  
• Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Did Not Respond to Fludarabine
  ClinicalTrials.gov Identifier: NCT00104858 - Recruiting
  refractory chronic lymphocytic leukemia; recurrent small lymphocytic lymphoma; B-cell Chronic Lymphocytic Leukemia; ...
  
• Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00086775 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003174 - Completed
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002844 - Active, not recruiting
  refractory chronic lymphocytic leukemia
  
• Treatment of Chronic Lymphocytic B-Leukemia with IL-2 and CD-40 Autologous Tumor Cells
  ClinicalTrials.gov Identifier: NCT00058786 - Active, not recruiting
  Chronic Lymphocytic B-Leukemia
  
• Study of Weekly Clofarabine for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00081887 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
  ClinicalTrials.gov Identifier: NCT00003635 - Completed
  refractory chronic lymphocytic leukemia; T-cell chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00098371 - Recruiting
  B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; refractory chronic lymphocytic leukemia
  
• Phase II Fludarabine, Cytoxan and FCCAM in Untreated B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00230282 - Recruiting
  B-Lymphocytic Leukemia, Chronic; Chronic Lymphocytic Leukemia
  
• Study of AQ4N for Safety and Activity in Patients with Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00109356 - Active, not recruiting
  Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia
  
• Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00076401 - Active, not recruiting
  Leukemia; Leukemia, Lymphocytic, Chronic
  
• Treatment of Chronic Lymphocytic Leukemia: DNA Microarray Gene Expression Analysis
  ClinicalTrials.gov Identifier: NCT00001586 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00074282 - Recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00077922 - Recruiting
  Leukemia; Lymphocytic; Chronic
  
• Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00002790 - Active, not recruiting
  Chronic Myelogenous Leukemia; Graft Versus Host Disease; childhood acute lymphocytic leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia; ...
  
• FR901228 and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00089336 - Not yet recruiting
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia
  
• 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Fludarabine and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia That Did Not Respond to Fludarabine
  ClinicalTrials.gov Identifier: NCT00098488 - Recruiting
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; Prolymphocytic Leukemia
  
• Study of Motexafin Gadolinium (MGd) in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00100711 - Active, not recruiting
  Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
  
• Safety and Dose Study of GRN163L Administered Weekly to Treat Patients with Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00124189 - Recruiting
  Lymphocytic Leukemia, Chronic
  
• Study of ONTAK in Patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00055146 - Recruiting
  Leukemia, Lymphocytic, Chronic
  
• Genasense™ (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects with Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00078234 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• Lumiliximab in Combination with Rituximab (FCR) in Subjects with Relapsed Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00103558 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00143065 - Active, not recruiting
  Lymphoma, Small Lymphocytic; Lymphocytic Leukemia, Chronic
  
• Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00021190 - No longer recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
  
• Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00022971 - Recruiting
  Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia
  
• Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002809 - Active, not recruiting
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ...
  
• Safety and Efficacy of SDX-101 (R-Etodolac) in Combination with Chlorambucil, and That of Chlorambucil Alone, in Patients with Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00151736 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003620 - Completed
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
  
• Haploid Allogeneic Transplant Using the CliniMACS System
  ClinicalTrials.gov Identifier: NCT00185679 - Recruiting
  Non-Hodgkin's Lymphoma; Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplastic Syndrome
  
• Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00045513 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; refractory chronic lymphocytic leukemia
  
• Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor
  ClinicalTrials.gov Identifier: NCT00393380 - Recruiting
  Leukemia, Myeloid, Chronic; Anemia, Aplastic; Myelofibrosis; Lymphoma; Hodgkin Disease; Leukemia, Lymphocytic, Chronic; Leukemia, Myelocytic, Acute; Leukemia, Lymphocytic, Acute
  
• Dose-finding Trial of CHIR-12.12 in Patients with Chronic Lymphocytic Leukemia (CLL) that is Relapsed or Non-responsive to Prior Therapy
  ClinicalTrials.gov Identifier: NCT00108108 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00049413 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia
  
• Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00079378 - Recruiting
  adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma
  
• Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From CLL
  ClinicalTrials.gov Identifier: NCT00464633 - Recruiting
  Leukemia, Lymphocytic, Chronic
  
• Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00006390 - Completed
  stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia; ...
  
• Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00201721 - Active, not recruiting
  B-Chronic Lymphocytic Leukemia
  
• Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00193518 - Active, not recruiting
  Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
  
• Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00096044 - Active, not recruiting
  refractory chronic lymphocytic leukemia
  
• FCR Plus Sargramostim (GM-CSF) as Frontline Therapy in Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00381004 - Recruiting
  Chronic Lymphocytic Leukemia; Leukemia
  
• Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004245 - Active, not recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00089154 - Active, not recruiting
  refractory chronic lymphocytic leukemia; noncontiguous stage II small lymphocytic lymphoma; recurrent small lymphocytic lymphoma; ...
  
• Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00058396 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia
  
• Stem Cell Transplant for Hematological Malignancy
  ClinicalTrials.gov Identifier: NCT00176930 - Recruiting
  Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-Hodgkin's Lymphoma; Multiple Myeloma
  
• Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia
  ClinicalTrials.gov Identifier: NCT00002832 - Active, not recruiting
  Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid; Leukemia, Lymphocytic
  
• Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00267059 - Active, not recruiting
  Chronic Lymphocytic Leukemia; Leukemia
  
• A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00419250 - Recruiting
  Chronic Lymphocytic Leukemia; Leukemia, B-Cell, Chronic
  
• Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)
  ClinicalTrials.gov Identifier: NCT00344825 - Active, not recruiting
  B- Chronic Lymphocytic Leukemia
  
• Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel
  ClinicalTrials.gov Identifier: NCT00159003 - Recruiting
  Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia
  
• Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00201682 - Active, not recruiting
  Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
  
• Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-Refractory Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00289549 - Recruiting
  Leukemia, Lymphocytic, Chronic
  
• A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00431873 - Recruiting
  Lymphocytic Leukemia, Chronic
  
• A Phase 1/2a Study of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00481091 - Recruiting
  Chronic Lymphocytic Leukemia
  
• A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00496132 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients
  ClinicalTrials.gov Identifier: NCT00558961 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002704 - Active, not recruiting
  B-cell childhood acute lymphocytic leukemia; TdT positive childhood acute lymphocytic leukemia; recurrent childhood acute lymphocytic leukemia; ...
  
• A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)
  ClinicalTrials.gov Identifier: NCT00302861 - Active, not recruiting
  B-Cell Chronic Lymphocytic Leukemia
  
• A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated
  ClinicalTrials.gov Identifier: NCT00233506 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
  ClinicalTrials.gov Identifier: NCT00290407 - Recruiting
  Leukemia, Lymphocytic, Chronic; Lymphoma, Small Lymphocytic
  
• Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003005 - Active, not recruiting
  recurrent adult acute lymphocytic leukemia; TdT positive adult acute lymphocytic leukemia; blastic phase chronic myelogenous leukemia
  
• Compassionate Use Program of Campath-1H in Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00021151 - Active, not recruiting
  refractory chronic lymphocytic leukemia; Prolymphocytic Leukemia
  
• Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia That Did Not Respond to Fludarabine (Closed to Entry as of 10/2006), Chronic Lymphocytic Leukemia With Autoimmune Hemolytic Anemia, or Richter Transformation
  ClinicalTrials.gov Identifier: NCT00309881 - Not yet recruiting
  Leukemia
  
• Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
  ClinicalTrials.gov Identifier: NCT00131313 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00022880 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
  ClinicalTrials.gov Identifier: NCT00071396 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00366418 - Recruiting
  Refractory Chronic Lymphocytic Leukemia
  
• Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination
  ClinicalTrials.gov Identifier: NCT00442130 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00062296 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia
  
• Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00082940 - Completed
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia
  
• Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00352677 - Recruiting
  Chronic Myeloid Leukemia; Acute Lymphocytic Leukemia
  
• Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00280241 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
  ClinicalTrials.gov Identifier: NCT00428233 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00514696 - Recruiting
  Chronic Lymphocytic Leukemia
  
• A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia.
  ClinicalTrials.gov Identifier: NCT00532129 - Recruiting
  Lymphocytic Leukemia, Chronic
  
• A Study of MabThera (Rituximab) in First Line Treatment of Chronic Lymphocytic Leukemia.
  ClinicalTrials.gov Identifier: NCT00545714 - Recruiting
  Lymphocytic Leukemia, Chronic
  
• FR901228 in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00088920 - Not yet recruiting
  adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma
  
• Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
  ClinicalTrials.gov Identifier: NCT00001637 - Active, not recruiting
  Chronic Lymphocytic Leukemia; Graft vs Host Disease; Leukemia; Myelodysplastic Syndrome; Myeloid Leukemia
  
• Study of Noscapine for Patients With Low Grade Non Hodgkin’s Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy
  ClinicalTrials.gov Identifier: NCT00183950 - Recruiting
  Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia